SMall Annuli Randomized To Evolut™ or SAPIEN™ Trial
NCT: NCT04722250 · ACTIVE_NOT_RECRUITING
Brief Summary
The purpose of this trial is to generate clinical evidence on valve safety and performance of self-expanding (SE) versus balloon-expandable (BE) transcatheter aortic valve replacement (TAVR) in subjects with a small aortic annulus and symptomatic severe native aortic stenosis. Additionally, a stress echocardiography sub-study will be conducted as part of the SMART Trial at select sites. The purpose of the sub-study is to evaluate performance of SE versus BE TAVR in subjects with a small aortic annulus and symptomatic severe native aortic stenosis after undergoing exercise stress echocardiographic testing.
Frequently Asked Questions
What is SMall Annuli Randomized To Evolut™ or SAPIEN™ Trial?
SMall Annuli Randomized To Evolut™ or SAPIEN™ Trial is a clinical trial registered under NCT04722250. Current status: ACTIVE_NOT_RECRUITING.
What is the status of NCT04722250?
The current status of NCT04722250 (SMall Annuli Randomized To Evolut™ or SAPIEN™ Trial) is: ACTIVE_NOT_RECRUITING.
When did SMall Annuli Randomized To Evolut™ or SAPIEN™ Trial start?
SMall Annuli Randomized To Evolut™ or SAPIEN™ Trial started on 2021-04-02.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.